Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion

Technology appraisal guidance
Reference number: TA283
Published: 22 May 2013
Last updated: 20 May 2024

Information for the public

Ranibizumab for macular oedema caused by retinal vein occlusion (PDF 162 KB)

Published:

22 May 2013
Gwybodaeth i'r cyhoedd (Word 116 KB)

Published:

07 October 2013